Esperion Therapeutics Inc - Asset Resilience Ratio

Latest as of December 2023: 0.00%

Esperion Therapeutics Inc (ESPR) has an Asset Resilience Ratio of 0.00% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$0.00

Cash + Short-term Investments

Total Assets

$205.80 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2002–2023)

This chart shows how Esperion Therapeutics Inc's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Esperion Therapeutics Inc to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Esperion Therapeutics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Esperion Therapeutics Inc stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$0.00	0%
Total Liquid Assets	$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Esperion Therapeutics Inc maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Esperion Therapeutics Inc Industry Peers by Asset Resilience Ratio

Compare Esperion Therapeutics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	48.48%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	15.57%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%

Annual Asset Resilience Ratio for Esperion Therapeutics Inc (2002–2023)

The table below shows the annual Asset Resilience Ratio data for Esperion Therapeutics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.00%	$0.00	$205.80 Million	--
2022-12-31	16.97%	$42.09 Million	$247.94 Million	+3.76pp
2021-12-31	13.22%	$50.44 Million	$381.59 Million	--
2020-12-31	0.00%	$0.00	$353.26 Million	--
2019-12-31	16.16%	$34.65 Million	$214.45 Million	-52.89pp
2018-12-31	69.05%	$99.05 Million	$143.45 Million	+9.40pp
2017-12-31	59.65%	$165.73 Million	$277.83 Million	-11.07pp
2016-12-31	70.72%	$173.42 Million	$245.21 Million	+25.07pp
2015-12-31	45.65%	$134.93 Million	$295.57 Million	+31.14pp
2014-12-31	14.51%	$20.80 Million	$143.34 Million	+10.01pp
2013-12-31	4.50%	$3.53 Million	$78.29 Million	-3.97pp
2002-12-31	8.47%	$4.35 Million	$51.41 Million	--

pp = percentage points

About Esperion Therapeutics Inc

NASDAQ:ESPR USA Drug Manufacturers - Specialty & Generic

Market Cap

$760.22 Million

Market Cap Rank

#10178 Global

#2726 in USA

Share Price

$3.18

Change (1 day)

+0.00%

52-Week Range

$1.49 - $4.08

All Time High

$80.76